Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 51% ± 20% | |
glutamatergic neuron | 13 studies | 68% ± 25% | |
GABAergic neuron | 10 studies | 54% ± 18% | |
interneuron | 6 studies | 63% ± 15% | |
neuron | 5 studies | 46% ± 18% | |
retina horizontal cell | 5 studies | 66% ± 26% | |
endothelial cell | 3 studies | 51% ± 23% | |
GABAergic interneuron | 3 studies | 48% ± 17% | |
granule cell | 3 studies | 45% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 43% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 1341.03 | 2568 / 2642 | 70% | 3.37 | 495 / 705 |
prostate | 84% | 252.82 | 207 / 245 | 18% | 0.63 | 88 / 502 |
kidney | 88% | 626.64 | 78 / 89 | 12% | 0.29 | 106 / 901 |
bladder | 52% | 70.38 | 11 / 21 | 9% | 0.25 | 45 / 504 |
thymus | 50% | 66.87 | 328 / 653 | 2% | 0.08 | 15 / 605 |
skin | 37% | 72.88 | 678 / 1809 | 7% | 0.16 | 32 / 472 |
ovary | 36% | 65.98 | 64 / 180 | 8% | 0.14 | 35 / 430 |
muscle | 42% | 63.73 | 340 / 803 | 0% | 0 | 0 / 0 |
esophagus | 3% | 2.67 | 41 / 1445 | 21% | 0.41 | 38 / 183 |
adipose | 21% | 24.54 | 257 / 1204 | 0% | 0 | 0 / 0 |
lung | 5% | 5.40 | 29 / 578 | 11% | 0.22 | 127 / 1155 |
breast | 14% | 17.08 | 64 / 459 | 2% | 0.03 | 17 / 1118 |
stomach | 8% | 9.84 | 28 / 359 | 7% | 0.09 | 19 / 286 |
pancreas | 0% | 0 | 0 / 328 | 14% | 0.25 | 25 / 178 |
intestine | 6% | 5.31 | 55 / 966 | 4% | 0.08 | 23 / 527 |
uterus | 5% | 6.27 | 9 / 170 | 4% | 0.09 | 20 / 459 |
adrenal gland | 1% | 2.67 | 3 / 258 | 3% | 0.07 | 7 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.39 | 1 / 29 |
blood vessel | 3% | 2.96 | 36 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
liver | 0% | 0 | 0 / 226 | 2% | 0.04 | 9 / 406 |
heart | 0% | 0.42 | 4 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.25 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_2000650 | Biological process | negative regulation of sodium ion transmembrane transporter activity |
GO_0048814 | Biological process | regulation of dendrite morphogenesis |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HECW1 |
Protein name | E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (hNEDL1) HECT-type E3 ubiquitin transferase (EC 2.3.2.26) |
Synonyms | NEDL1 KIAA0322 |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1. Also targets the mutant SOD1 protein involved in familial amyotrophic lateral sclerosis (FALS). Forms cytotoxic aggregates with DVL1, SSR3 and mutant SOD1 that lead to motor neuron death in FALS. . |
Accessions | ENST00000453890.5 [Q76N89-2] ENST00000395891.7 [Q76N89-1] H7C3Q2 Q76N89 ENST00000429529.1 |